Silvercrest Asset Management Group LLC lifted its stake in Encompass Health Co. (NYSE:EHC – Free Report) by 1.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 251,990 shares of the company’s stock after buying an additional 4,258 shares during the period. Silvercrest Asset Management Group LLC owned approximately 0.25% of Encompass Health worth $20,809,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the stock. Principal Securities Inc. purchased a new stake in shares of Encompass Health during the fourth quarter valued at approximately $25,000. Benjamin F. Edwards & Company Inc. grew its stake in shares of Encompass Health by 360.2% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock valued at $27,000 after acquiring an additional 317 shares in the last quarter. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Encompass Health during the fourth quarter worth about $30,000. GAMMA Investing LLC acquired a new position in shares of Encompass Health in the fourth quarter worth about $33,000. Finally, Parallel Advisors LLC boosted its holdings in Encompass Health by 192.3% in the fourth quarter. Parallel Advisors LLC now owns 573 shares of the company’s stock valued at $38,000 after purchasing an additional 377 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Encompass Health
In other news, insider Elissa Joy Charbonneau sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $85.02, for a total transaction of $850,200.00. Following the completion of the transaction, the insider now directly owns 18,594 shares in the company, valued at $1,580,861.88. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, insider Elissa Joy Charbonneau sold 10,000 shares of the firm’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $85.02, for a total transaction of $850,200.00. Following the transaction, the insider now directly owns 18,594 shares of the company’s stock, valued at $1,580,861.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John Patrick Darby sold 14,543 shares of the company’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $83.94, for a total transaction of $1,220,739.42. Following the completion of the sale, the executive vice president now directly owns 84,773 shares of the company’s stock, valued at approximately $7,115,845.62. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on Encompass Health
Encompass Health Stock Performance
EHC traded up $0.46 during trading on Tuesday, reaching $91.96. 710,463 shares of the company were exchanged, compared to its average volume of 632,654. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.14. The stock has a market cap of $9.26 billion, a P/E ratio of 24.80, a PEG ratio of 1.43 and a beta of 0.89. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $92.69. The firm has a 50 day moving average of $85.70 and a 200 day moving average of $80.46.
Encompass Health Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Tuesday, October 1st. This is a boost from Encompass Health’s previous quarterly dividend of $0.15. Encompass Health’s dividend payout ratio (DPR) is 16.22%.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Articles
- Five stocks we like better than Encompass Health
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- 5 discounted opportunities for dividend growth investors
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- What Investors Need to Know to Beat the Market
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.